Enhanced cord blood stem cell transplants safe in long-term studies
Monday, April 18, 2011 - 10:00
in Health & Medicine
An innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, report scientists from Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center (BIDMC), and Children's Hospital Boston (CHB).